Crossmark

In silico drug repurposing for coronavirus (COVID-19): screening known HCV drugs against the SARS-CoV-2 spike protein bound to angiotensin-converting enzyme 2 (ACE2) (6M0J)

Crossref DOI link: https://doi.org/10.1007/s11030-022-10469-7

Published Online: 2022-06-23

Published Print: 2023-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kalamatianos, Konstantinos G. https://orcid.org/0000-0002-0276-6531
License Information

Text and Data Mining valid from 2022-06-23

Version of Record valid from 2022-06-23
More Information

Article History

Received: 1 October 2021

Accepted: 24 May 2022

First Online: 23 June 2022

Declarations

:

: No potential conflict of interest is reported by the author.

Free to read: This content has been made available to all.

Document is current

Any future updates will be listed below